AA
54
-7
AON
63
-2
AMAT
43
11
AVB
35
-5
BAX
38
-3
AKAM
42
2
AEP
64
-3
AXP
62
2
AEE
64
-2
AVY
37
-4
AIV
47
10
ABT
47
-3
AMGN
25
-5
APA
48
-2
AIZ
76
-2
BAC
62
3
APD
45
-4
APH
59
3
ADBE
47
2
BIIB
51
-5
AA
54
-7
AON
63
-2
AMAT
43
11
AVB
35
-5
BAX
38
-3
AKAM
42
2
AEP
64
-3
AXP
62
2
AEE
64
-2
AVY
37
-4
AIV
47
10
ABT
47
-3
AMGN
25
-5
APA
48
-2
AIZ
76
-2
BAC
62
3
APD
45
-4
APH
59
3
ADBE
47
2
BIIB
51
-5
Financhill
Back

iShares LifePath Target Date 2040 ETF Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
91

ITDD
iShares LifePath Target Date 2040 ETF

Last Price:
$33.84
Seasonality Move:
6.9%
Buy
70

SRPT
Sarepta Therapeutics

Last Price:
$20.57
Seasonality Move:
8.12%
Buy
91
iShares LifePath Target Date 2040 ETF (ITDD) is a Buy

Is iShares LifePath Target Date 2040 ETF a Buy, Sell or Hold?

  • The current iShares LifePath Target Date 2040 ETF [ITDD] share price is $33.95. The Score for ITDD is 91, which is 82% above its historic median score of 50, and infers lower risk than normal.
  • ITDD is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
70
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $21.81. The Score for SRPT is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ITDD Stock Price Chart

What is iShares LifePath Target Date 2040 ETF's stock price today?

  • The iShares LifePath Target Date 2040 ETF share price today is $33.95
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITDD is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $21.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

ITDD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.26 Buy
Relative Strength Index (14 RSI): 67.63 Buy
Chaikin Money Flow: 170 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.03 Buy
Relative Strength Index (14 RSI): 61.42 Buy
Chaikin Money Flow: 6597638 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

ITDD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.75 Buy
20-day SMA: 33.53 Buy
50-day SMA: 33.02 Buy
200-day SMA: 31.5 Buy
8-day EMA: 33.78 Buy
20-day EMA: 33.54 Buy
50-day EMA: 32.99 Buy
200-day EMA: 31.55 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.96 Buy
20-day SMA: 16.47 Buy
50-day SMA: 20.62 Buy
200-day SMA: 75.35 Sell
8-day EMA: 18.91 Buy
20-day EMA: 13.99 Buy
50-day EMA: 7.79 Buy
200-day EMA: 2.35 Buy

iShares LifePath Target Date 2040 ETF Earnings Growth & ITDD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.34 per share, an increase next quarter of $1.27 per share, a decrease this year of $5.65 per share, and an increase next year of $5.32 per share.

iShares LifePath Target Date 2040 ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):